Medications for Weight Management

1. Obesity is defined as a chronic progressive, relapsing, and treatable multi-factorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces, resulting in adverse metabolic biomechanical, and psychosocial health consequences.

a) True
b) False

2. Class three obesity is defined as a Body Mass Index (BMI) greater than or equal to 40.

a) True
b) False

3. Metabolic Syndrome can be diagnosed if a patient presents with hypertension, hypertriglyceridemia, and elevated fasting glucose.

a) True
b) False

4. Obesity, as a chronic disease, is multifactorial and may require intervention in the following area(s):

a) Nutrition
b) Physical activity
c) Behavioral modification
d) Medical interventions
e) All of the above

5. Waist circumference target ranges can vary based on ethnicity.

a) True
b) False

6. The following resulting factor(s) occur with an increase in adiposity:

a) Increase in proinflammatory cytokines
b) Release of free fatty acids
c) Increased activity of the sympathetic nervous system
d) Mechanical stress
e) All of the above

7. Obesity increases the risk of 13 cancer types.

a) True
b) False

8. The following are part of the 5 A’s of obesity management:

a) Ask
b) Assess
c) Advise
d) Arrange/assist
e) All of the above

9. Sustained weight loss of greater than 10% usually confers greater benefits, including disease-modifying effects and possible remission of type 2 diabetes, and may improve long-term cardiovascular outcomes.

a) True
b) False